Literature DB >> 3583467

Pharmacokinetics of flufenamic acid in man.

E G Lentjes, C A van Ginneken.   

Abstract

Flufenamic acid (200 mg) was administered in the form of a soft capsule to 8 young healthy volunteers after an overnight fast. The drug was absorbed irregularly and plasma curves showed large variation. Peak plasma concentrations varied strongly (6-20 micrograms/ml) but were usually reached within 1.5 h. The terminal elimination half-life is long (5-22 h) and the total body clearance is low (80-150 ml/min) causing long mean residence time (4-28 h). The total apparent volume of distribution is much larger than the total body water volume. The large intersubject variations led to the conclusion that mean values of the pharmacokinetic parameters of flufenamic acid after oral administration are not useful for practical purposes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3583467

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  6 in total

1.  Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.

Authors:  Ravi S Kasinathan; Michael Föller; Saisudha Koka; Stephan M Huber; Florian Lang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-19       Impact factor: 3.000

2.  In vitro analysis of flufenamic acid activity against Candida albicans biofilms.

Authors:  Alba A Chavez-Dozal; Maximillian Jahng; Hallie S Rane; Kingsley Asare; Vibhati V Kulkarny; Stella M Bernardo; Samuel A Lee
Journal:  Int J Antimicrob Agents       Date:  2013-10-01       Impact factor: 5.283

Review 3.  Flufenamic acid as an ion channel modulator.

Authors:  Romain Guinamard; Christophe Simard; Christopher Del Negro
Journal:  Pharmacol Ther       Date:  2013-01-25       Impact factor: 12.310

4.  Repurposing Fenamic Acid Drugs To Combat Multidrug-Resistant Neisseria gonorrhoeae.

Authors:  Young Jin Seong; Marwa Alhashimi; Abdelrahman Mayhoub; Haroon Mohammad; Mohamed N Seleem
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

5.  Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.

Authors:  Luiz F Zerbini; Rodrigo E Tamura; Ricardo G Correa; Akos Czibere; Jason Cordeiro; Manoj Bhasin; Fernando M Simabuco; Yihong Wang; Xuesong Gu; Linglin Li; Devanand Sarkar; Jin-Rong Zhou; Paul B Fisher; Towia A Libermann
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

6.  Dissolution Behavior of Flufenamic Acid in Heated Mixtures with Nanocellulose.

Authors:  Athanasios Mantas; Albert Mihranyan
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.